Bell RS - Search Results

1

Expression of insulin-like growth factor receptor, IGF-1, and IGF-2 in primary and metastatic osteosarcoma.

Burrow S, Andrulis IL, Pollak M, Bell RS. Burrow S, et al. Among authors: bell rs. J Surg Oncol. 1998 Sep;69(1):21-7. doi: 10.1002/(sici)1096-9098(199809)69:1<21::aid-jso5>3.0.co;2-m. J Surg Oncol. 1998. PMID: 9762887

2

Reduced growth of human sarcoma xenografts in hosts homozygous for the lit mutation.

Deitel K, Dantzer D, Ferguson P, Pollak M, Beamer W, Andrulis I, Bell R. Deitel K, et al. J Surg Oncol. 2002 Oct;81(2):75-9. doi: 10.1002/jso.10136. J Surg Oncol. 2002. PMID: 12355407

3

Insulin-like growth factor 1 (IGF-1) receptors, IGF-1, and IGF-2 are expressed in primary human sarcomas.

Sekyi-Otu A, Bell RS, Ohashi C, Pollak M, Andrulis IL. Sekyi-Otu A, et al. Among authors: bell rs. Cancer Res. 1995 Jan 1;55(1):129-34. Cancer Res. 1995. PMID: 7805022

4

Quantitative analysis of multidrug resistance gene expression in human osteosarcomas.

Lee PD, Noble-Topham SE, Bell RS, Andrulis IL. Lee PD, et al. Among authors: bell rs. Br J Cancer. 1996 Oct;74(7):1046-50. doi: 10.1038/bjc.1996.487. Br J Cancer. 1996. PMID: 8855972 Free PMC article.

5

SAS is amplified predominantly in surface osteosarcoma.

Noble-Topham SE, Burrow SR, Eppert K, Kandel RA, Meltzer PS, Bell RS, Andrulis IL. Noble-Topham SE, et al. Among authors: bell rs. J Orthop Res. 1996 Sep;14(5):700-5. doi: 10.1002/jor.1100140504. J Orthop Res. 1996. PMID: 8893761

6

MDR1 gene expression and outcome in osteosarcoma: a prospective, multicenter study.

Wunder JS, Bull SB, Aneliunas V, Lee PD, Davis AM, Beauchamp CP, Conrad EU, Grimer RJ, Healey JH, Rock MJ, Bell RS, Andrulis IL. Wunder JS, et al. Among authors: bell rs. J Clin Oncol. 2000 Jul;18(14):2685-94. doi: 10.1200/JCO.2000.18.14.2685. J Clin Oncol. 2000. PMID: 10894867

7

Comparison of p53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma.

Gokgoz N, Wunder JS, Mousses S, Eskandarian S, Bell RS, Andrulis IL. Gokgoz N, et al. Among authors: bell rs. Cancer. 2001 Oct 15;92(8):2181-9. doi: 10.1002/1097-0142(20011015)92:8<2181::aid-cncr1561>3.0.co;2-3. Cancer. 2001. PMID: 11596036

8

Metastatic behavior of the RIF-1 murine fibrosarcoma: inhibited by hypophysectomy and partially restored by growth hormone replacement.

Sekyi-Otu A, Bell R, Andrulis I, Pollak M. Sekyi-Otu A, et al. J Natl Cancer Inst. 1994 Apr 20;86(8):628-32. doi: 10.1093/jnci/86.8.628. J Natl Cancer Inst. 1994. PMID: 8145278

9

TP53 mutations and outcome in osteosarcoma: a prospective, multicenter study.

Wunder JS, Gokgoz N, Parkes R, Bull SB, Eskandarian S, Davis AM, Beauchamp CP, Conrad EU, Grimer RJ, Healey JH, Malkin D, Mangham DC, Rock MJ, Bell RS, Andrulis IL. Wunder JS, et al. Among authors: bell rs. J Clin Oncol. 2005 Mar 1;23(7):1483-90. doi: 10.1200/JCO.2005.04.074. J Clin Oncol. 2005. PMID: 15735124

10

hCDC4 variation in osteosarcoma.

Yan T, Wunder JS, Gokgoz N, Seto KK, Bell RS, Andrulis IL. Yan T, et al. Among authors: bell rs. Cancer Genet Cytogenet. 2006 Sep;169(2):138-42. doi: 10.1016/j.cancergencyto.2006.04.007. Cancer Genet Cytogenet. 2006. PMID: 16938571

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

241 results

Search Page